RESEARCH TRIANGLE PARK, N.C., Jan. 23, 2018 -- JAGGAER, the world’s largest independent spend management company, has created an ultra-efficient procurement process for the Fred Hutchinson Cancer Research Center (Fred Hutch), enabling more time to be spent on groundbreaking cancer research. For nearly a decade, Fred Hutch has used JAGGAER’s eProcurement solution to push 85% of spend under management, to reduce buyers on staff by 20%, and to increase the volume of grant revenue it handles by 8x.
“When we first approached JAGGAER in 2009, we had just broken ground on a new facility and planned to add two more within the next ten years. Our procurement process wasn’t sustainable, and we knew we needed a solution that would grow with us and would help alleviate the time-consuming processes that were detracting from valuable research time. JAGGAER’s eProcurement solution saves each of our investigators up to 90 minutes daily – time that used to be spent managing lab supplies can now be put toward the next cancer drug or immunotherapy breakthrough,” said Mark Burch, Director of Materials at Fred Hutch. “At Fred Hutch, we don’t work with just anybody. We seek partners who bring the same skills, focus, and energy on which we pride ourselves.”
JAGGAER has improved confidence within the labs at Fred Hutch. 72% of requisitions are converted to POs on the same day, with another 18% that go through the next day. Items are received in one-third of the original time – on average one to three days. The quick turnaround time allows scientists to operate closer to a “just-in-time” process, and not have to stockpile materials. In addition to time saved, this reduction in inventory costs has been the leading cost-saver for Fred Hutch.
“Cost savings is always an important factor to our customers, but for research centers like Fred Hutch, time savings is one of the most valuable assets. Digitalizing and automating outdated, manual procurement processes with our solutions has enabled hundreds of life science organizations across the world to dedicate more time to their core mission,” said Robert Bonavito, CEO of JAGGAER.
About Fred Hutchinson Cancer Research Center
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.
About JAGGAER: Global Indirect and Direct Spend Management Solutions
JAGGAER is the world’s largest independent spend management company, with over 1,850 customers connected to a network of 3.7 million suppliers in 70 countries, served by offices located in North America, Latin America, throughout Europe, the United Kingdom, Australia, Asia, and the Middle East. JAGGAER offers complete SaaS based indirect and direct eProcurement solutions with advanced spend analytics, complex sourcing, supplier management, contract lifecycle management, savings tracking, and intelligent workflow capabilities. We have pioneered spend solutions for over two decades and continue to lead the innovation curve by listening to customers and analyzing the market. Our solutions suites are trusted by the world’s largest education, manufacturing, health care, retail, consumer package goods, logistics, construction, utilities companies and public service organizations. Additionally, JAGGAER holds 38 patents–more than any other spend management company. www.JAGGAER.com
To join the conversation, please visit our blog at https://JAGGAER.com/blog/ or follow us on Twitter @JaggaerPro
MEDIA CONTACT
[email protected]
919-659-NEWS
JAGGAER Presents REV2018: Educate – Innovate – Accelerate
Join us for our annual conference: JAGGAER.com/REV/


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Instagram Outage Disrupts Thousands of U.S. Users
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



